open link in new page
Discussion of the role of stigma in underutilization and solutions to reduce stigma and expand access to MAT (2019) learn more
4/48/21 -
open link in new page
Updated guidelines for prescribing Buprenorphine. learn more
open link in new page
Methadone treatment in jails and prisons (2019). learn more
open link in new page
SUD treatment in Jails (2019). learn more
open link in new page
The benefit of methadone maintenance in jails: less likely to receive disciplinary tickets, more likely to engage in treatment once released (2018). learn more
open link in new page
Best practices for SUD treatment in jails, from the perspective of the National Sheriff's Association and NCCHC (2018). learn more
open link in new page
NCCHC position statement on Opioid Use Disorder Treatment in jails, including screening, assessment, care coordination, MAT, and psychosocial treatment (2016). learn more
open link in new page
NCCHC position paper supporting the use of Naloxone and the education of all jail staff including health and custody staff on the use of Naloxone (2015). learn more
open link in new page
Paper supporting the ethical imperative to provide MAT/MOUD in jails (2019). learn more
open link in new page
NYT Opinion piece on the need for SUD treatment programs in jails (2017). learn more
open link in new page
Discussion of gaps in access to treatment for OUD in jail facilities in the US (2019). learn more
open link in new page
The sheriff of Hampden County, Massachusetts, describes the county’s efforts to help break the cycle of reincarceration by ensuring that inmates get high-quality health care in and out of jail (2014). learn more
open link in new page
Article explores the consequences of poor addiction treatment policies in U.S. prisons (2018). learn more
open link in new page
Case discussion of a man who sued a jail in Massachusetts for violating the ADA by not allowing him MAT in jail (2019). learn more
open link in new page
The Massachusetts U.S. attorney is investigating whether state prison officials are violating federal law by forcing inmates to stop taking their addiction medication when behind bars (2018). learn more
open link in new page
Review of the Rhode Island Department of Corrections MAT program with a discussion of the different FDA approved medications (2019). learn more
open link in new page
Review of a court case: The United States Court of Appeals for the First Circuit in Boston ruled in favor of providing MAT to a defendant in jail (2019). learn more
open link in new page
Review of Rhode Island Department of Corrections MAT program (2018). learn more
open link in new page
Review of jails in several states using MAT in custody (2019). learn more
open link in new page
Discussion of how fentanyl has changed the prison experience for prisoners and custody (2019). learn more
open link in new page
Insights on treating alcohol withdrawal gained by an ER physician after intensively treating alcohol withdrawal in a county jail (2017). learn more
open link in new page
Findings suggest: Buprenorphine administered to non-opioid-tolerant adults can be successfully inducted prior to release at a lower dose than used for adults actively using opioids (2015). learn more
open link in new page
List of resources and information sheets on working with justice involved women (2020). learn more
open link in new page
Review of the economic benefit of SUD treatment offered in custody including savings in health care, lost productivity, crime, and incarceration (2014). learn more
open link in new page
Review of the NAT in Detention Act, which would require jails and prisons in Maryland to provide access to all three FDA-approved medications for OUD during incarceration (2019). learn more
open link in new page
Screening instruments for all intercept points in the criminal justice system (2008). learn more
open link in new page
Report provides background on those who fatally overdosed in 2016, details the connections they had to the criminal justice system, and locates possible opportunities for intervention (2017). learn more
open link in new page
Condensed from the SAMHSA publication: Clinical Use of Extended-Release Injectable Naltrexone in the Treatment of Opioid Use Disorder: A Brief Guide (2014). learn more
open link in new page
Implications from overdose deaths data on public health practice (2017). learn more
open link in new page
Spreadsheet details estimates of opioid users in California county jails (2019). learn more
open link in new page
Document provides information and details of active MAT programs in jails nationally. Compiled by Advocates for Human Potential (2017). learn more
open link in new page
Board resolution supporting the use of MAT in drug courts. learn more
open link in new page
White paper with recommendations from the National DA's Assoc. on how to impact the opioid epidemic, including recommendations on enforcement, prevention and treatment (2018). learn more
open link in new page
Recommendation for opioid court based on a cumulative effort of a working group (2019). learn more
open link in new page
FAQ/General Information. learn more
open link in new page
Discussion of barriers to MAT for probationers, including stigma, cost and diversion risk, among others. learn more
open link in new page
Best practices and guidelines for supporting MAT treatment in Adult drug court. learn more
open link in new page
Strategies for dealing with MAT in drug courts. learn more
open link in new page
Best Practice/Policy/Guideline. learn more
open link in new page
Reviews interventions in a small town near Boston, through the Opioid Task Force, such as MAT and DBT in jail, and job training (2018). learn more
open link in new page
Review of USA jails that provide MAT, which medications are provided by state, and obstacles to treatment (2018). learn more
open link in new page
Review and discussion of a potential paradigm shift for addiction medicine, as New Jersey’s health commissioner this week authorized paramedics to administer the drug buprenorphine to patients almost immediately after reviving them from an opioid overdo... learn more
open link in new page
NIH formed the Justice Community Opioid Innovation Network (JCOIN) to support research on quality treatment for Opioid Use Disorder in Criminal Justice settings nationwide (2019). learn more
open link in new page
Review of the partnership between The Executive Office of Health and Human Services (EOHHS) and members of law enforcement to strengthen treatment for justice-involved individuals with behavioral health needs re-entering the community (2019). learn more
4-18-2022 -
open link in new page
This document lists BayMark Health Services Clinic in CA as of 4/18/2022. learn more
04/05/2022 -
open link in new page
From the U.S. Department of Justice, Civil Rights Division learn more
3-8-2023 -
open link in new page
open link in new page
Benefits and barriers to providing telehealth MAT services, description of 11 agencies providing these services (2019). learn more
open link in new page
Systematic assessment of past, present and possible futures of fentanyl in the US (2019). learn more
open link in new page
Joint policy statement includes recommendations to support correctional policy makers and correctional healthcare professionals in providing evidence-based care to those in their custody or under their supervision who have an opioid use disorder (2018). learn more
open link in new page
Ethics review of why it’s inappropriate not to treat incarcerated patients with opioid agonist therapy (2017). learn more
open link in new page
Recommendations for Medication-Assisted Treatment of Adolescents with Opioid Use Disorders (2016). learn more
open link in new page
Legal Interventions to Reduce Overdose Mortality: Naloxone Access and Overdose Good Samaritan Laws (2018). learn more
open link in new page
Review of the legal liabilities of denying access to MAT in the criminal justice system, including violation of the ADA and the Rehabilitation Act, the 8th amendment, and the 14th amendment (2011). learn more
open link in new page
Guidance to state governments on increasing the availability of evidence-based medication-assisted treatment (MAT) in criminal justice settings (2019). learn more
open link in new page
Common objections and evidence-based responses that are often raised in correctional settings (2019). learn more
open link in new page
NIH general guide for treatment as well as FAQ's on SUD treatment in the criminal justice system (Rev. 2014). learn more
open link in new page
FAQ/fact sheet about fentanyl (2019). learn more
open link in new page
General information webpage on Neonatal Abstinence Syndrome (NAS) including signs, symptoms, causes, testing, and treatment (2019). learn more
open link in new page
Infographic on preventing NAS in baby's (2018). learn more
open link in new page
Infographic: Emerging Treatment Options for Neonatal Abstinence Syndrome (2019). learn more
open link in new page
open link in new page
Mother to Baby general information factsheet on Oxycodone (updated Nov., 2020). learn more
open link in new page
General information webpage on prescription opioids during pregnancy (June, 2019). learn more
open link in new page
General information webpage on Heroin and Pregnancy including problems and resources (Sept., 2020). learn more
open link in new page
Dr. Siobhan Dolan explains on Youtube how taking some prescription medicines before or during pregnancy can hurt your baby (Feb., 2015). learn more
open link in new page
The California Department of Public Health Youtube PSA to educate moms-to-be and families about the risks associated with opioids during pregnancy (Aug., 2019). learn more
November 2020 -
open link in new page
This brief provides information jails can use in deciding whether to keep incarcerated persons on extended release naltrexone or switch them to oral naltrexone tablets. learn more
open link in new page
recommendations for prevention, treatment and recovery in rural communities learn more
open link in new page
We have put together a list of questions that are frequently asked by team members. We have included references with our responses. learn more
09/07/2021 -
open link in new page
How can healthcare providers advocate for their patients with Substance Use Disorders who are involved in the criminal justice system? learn more
3-22-2023 -
open link in new page
open link in new page
Behavioral health treatment and Buprenorphine: Researchers found similar outcome results for buprenorphine treatment with and without CBT. learn more
open link in new page
Behavioral health treatment and Buprenorphine compared for treatment conditions: CBT, Contingency management (CM), CBT and CM, and no treatment. Researchers found no differences among groups. learn more
open link in new page
Behavioral health treatment and suboxone: Comparison of treatment outcomes of suboxone with and without behavioral health treatment. learn more
open link in new page
Qualitative study of use, characteristics of use, and experiences of Suboxone use among polysubstance users entering programs (2018). learn more
open link in new page
Comparison of physician management of suboxone in HIV treatment settings versus physician management plus counseling. No difference was found in outcomes (2012). learn more
open link in new page
Reviews history of fentanyl use, future of fentanyl use, potential innovative policy options. learn more
open link in new page
Comparison of treatment outcomes for extended release naltrexone and usual treatment. Those assigned to naltrexone had a lower rate of relapse and a longer period of time before relapse (2016). learn more
open link in new page
Review of research on efficacy of psychosocial interventions used with MAT. Results generally support the use of psychosocial interventions with MAT although gaps in the literature and the need for future research were noted (2016). learn more
open link in new page
Researchers suggest people getting Vivitrol shots may be more susceptible to a fatal overdose if they halt the regimen early and resume using opiates (2018). learn more
open link in new page
Patients who receive buprenorphine while on waiting lists for opioid treatment have higher rates of sobriety than those who do not (2016). learn more
open link in new page
Research review indicates retention in methadone and buprenorphine treatment is associated with substantial reductions in the risk for all cause and overdose mortality in people dependent on opioids (2017). learn more
open link in new page
Majority of defendants in RI DOC continued treatment post release. Barriers to treatment for those who did not continue are explored (2019). learn more
open link in new page
Meta-analysis demonstrated the effectiveness of MAT treatment in correctional settings (2019). learn more
open link in new page
Review identified medication and behavioral factors associated with MAT treatment retention (2019). learn more
open link in new page
Quantitative and qualitative study finds 12-step attendance is associated with better outcomes in MAT treatment over the first 6 months of treatment, but if required to attend by counselors, there was no treatment effect (2015). learn more
open link in new page
Study of community outreach program demonstrates effectiveness of this intervention (2020). learn more
open link in new page
Retrospective study on Buprenorphine found those in treatment for longer did better than those in short term treatment; however, the risk of overdose was high for both groups following Buprenorphine treatment discontinuation (2019). learn more
open link in new page
Study found patients who used methamphetamine were less likely to be retained in treatment than non-methamphetamine users. However, for people who were retained, methamphetamine use decreased over time (2019). learn more
open link in new page
Methadone and buprenorphine were associated with reduced overdose and opioid-related morbidity compared with opioid antagonist therapy, inpatient treatment, or intensive outpatient behavioral interventions (2020). learn more
open link in new page
Study of unintentional overdose deaths in RI before and after they implemented a MAT program. MAT program led to a 12.3% reduction in deaths (2017). learn more
open link in new page
Best practices and guidelines for working with adolescents with OUD (2016). learn more
open link in new page
Study demonstrated reduced cravings for marijuana in young marijuana users treated with NAC (2010). learn more
open link in new page
Qualitative study on motivation and barriers for pregnant women, based on 20 interviews of pregnant women in OUD treatment (2019). learn more